Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / EVLO - Evelo drops as mid-stage trial for psoriasis drug fails

EVLO - Evelo drops as mid-stage trial for psoriasis drug fails

October, 17 2023 09:12 AM Evelo Biosciences Inc.

2023-10-17 09:12:50 ET

More on Evelo

Evelo Biosciences: May Be Worth A Small, Highly Speculative Long Position Considering Upcoming Psoriasis Phase 2 Results
Circling Back On Evelo Biosciences
Evelo Biosciences enters into termination and surrender pact with Bio-Rad
Seeking Alpha’s Quant Rating on Evelo Biosciences
Historical earnings data for Evelo Biosciences

For further details see:

Evelo drops as mid-stage trial for psoriasis drug fails

Stock Information

Company Name:	Evelo Biosciences Inc.
Stock Symbol:	EVLO
Market:	OTC
Website:	evelobio.com

EVLO EVLO Quote EVLO Short EVLO News EVLO Articles EVLO Message Board

Get EVLO Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.